Body mass index percentiles for Turkish children aged 0-84 months

Meda Kondolot1, Elcin Balci, Ahmet Ozturk

  • 1Unit of Social Pediatrics, Department of Pediatrics, Erciyes University, Kayseri, Turkey. medakondolot@gmail.com

Annals of Human Biology
|October 1, 2011
PubMed

Insights

Turkish children aged 0-84 months show higher body mass index (BMI) percentiles than World Health Organization (WHO) standards. This study establishes crucial BMI references and obesity prevalence data for this demographic.

Area of Science:

  • Pediatric Endocrinology
  • Public Health Nutrition
  • Child Growth Monitoring

Background:

  • Establishing reference body mass index (BMI) percentiles is crucial for tracking secular trends in Turkish children aged 0-84 months.
  • Obesity prevalence data in this young age group is currently limited, necessitating updated research.

Purpose of the Study:

  • To determine BMI percentiles for Turkish children aged 0-84 months.
  • To ascertain the prevalence of overweight and obesity in this population.
  • To compare the obtained BMI status with World Health Organization (WHO) growth standards.

Main Methods:

  • Utilized data from the Anthropometry of Turkish Children aged 0-6 years (ATCA-06) study.
  • Conducted a cross-sectional analysis of 2683 children (aged 0-84 months) in Kayseri, Turkey, between September 2009 and May 2010.
  • Constructed centile curves using the established LMS method.

Main Results:

  • Turkish children exhibited higher BMI percentiles compared to WHO standards during early childhood.
  • Overweight prevalence was 10.0% and obesity prevalence was 4.9% in both genders.
  • Identical prevalence rates for overweight and obesity were observed between male and female participants.

Conclusions:

  • This research provides essential BMI reference values and prevalence data for overweight and obesity among children aged 0-84 months in Kayseri, Turkey.
  • The generated data can facilitate the monitoring of secular changes in child growth.
  • Findings support international comparisons and inform public health strategies regarding childhood obesity.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Percentile01:18

Percentile

A percentile indicates the relative standing of a data value when data are sorted into numerical order from smallest to largest. It represents the percentages of data values that are less than or equal to the pth percentile. For example, 15% of data values are less than or equal to the 15th percentile. Low percentiles always correspond to lower data values. High percentiles always correspond to higher data values.Percentiles divide ordered data into hundredths. To score in the...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...